These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 15801998)

  • 1. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK.
    Guest JF; Ruiz FJ; Greener MJ; Trotman IF
    Eur J Cancer Care (Engl); 2006 Mar; 15(1):65-73. PubMed ID: 16441679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
    Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
    Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy.
    Roggeri D; Saramin C; Terrazzani G; Zusso M; Giusti P; Chinellato A
    Pharmacol Res; 2007 Oct; 56(4):329-34. PubMed ID: 17851088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
    Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
    J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.
    Guest JF; Hart WM; Cookson RF
    Pharmacoeconomics; 1998 Sep; 14(3):285-97. PubMed ID: 10186467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid use in palliative care of children and young people with cancer.
    Hewitt M; Goldman A; Collins GS; Childs M; Hain R
    J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
    Binhas M; Krakowski I; Marty J
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study.
    Chung CP; Dupont WD; Murray KT; Hall K; Stein CM; Ray WA
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):48-53. PubMed ID: 30003613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
    Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
    BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.